Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Advances in Experimental Medicine and Biology|January 1, 1988
Protease histochemistry in normal and uremic ratsR Gossrau, A Heidland, J Haunschild
Histochemistry|January 1, 1988
Enzyme cytochemistry of rat organs after uremia with special reference to proteasesR Gossrau, A Heidland, J Haunschild
Cellular and Molecular Biology (Noisy-Le-Grand, France)|February 1, 1995
Distribution of humanized MAb 425 (EMD 62,000) in rats and specific localization in tumor-bearing nude miceK Steiner, J Haunschild, H P Faro, et al.
Cell Biophysics|June 1, 1995
Pharmacokinetics of reshaped MAb 425 in three animal speciesJ Haunschild, K Steiner, H P Faro, et al.
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|November 25, 2011
Antiviral activity in vitro of two preparations of the herbal medicinal product Sinupret® against viruses causing respiratory infectionsB Glatthaar-Saalmüller, U Rauchhaus, S Rode, et al.
European Journal of Immunology|October 1, 1993
Mitogenicity of anti-Thy-1 monoclonal antibodies attributable to an Fc-dependent mechanismU Kummer, J Haunschild, G Reisbach, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 1996
In vivo evaluation of epidermal growth factor (EGF) receptor density on human tumor xenografts using radiolabeled EGF and anti-(EGF receptor) mAb 425R Senekowitsch-Schmidtke, K Steiner, J Haunschild, et al.
Burns : Journal of the International Society for Burn Injuries|April 20, 2006
A recombinant anti-ICAM-1 Fab fragment is as effective as the complete IgG antibody in treatment of burns in rabbitsP Ch Fuchs, T L Hartmann, C Schrimpf, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 16, 2001
Studies comparing in vivo:in vitro metabolism of three pharmaceutical compounds in rat, dog, monkey, and human using cryopreserved hepatocytes, microsomes, and collagen gel immobilized hepatocyte culturesN J Hewitt, K U Bühring, J Dasenbrock, et al.
The British Journal of Dermatology|September 27, 2005
Efficacy of the fully human monoclonal antibody MOR102 (#5) against intercellular adhesion molecule 1 in the psoriasis-severe combined immunodeficient mouse modelW-H Boehncke, F R Ochsendorf, S Noll, et al.
Pageof 1